Hydrogen Therapy Helps 85-Year-Old Woman with Severe Lung Disease

TL;DR

Breathing in hydrogen helped improve lung function in an elderly woman with a severe lung scarring condition and pneumonia.

Key Finding

An 85-year-old patient with severe lung scarring disease showed clinical improvement within four days of hydrogen gas therapy, including improved lung imaging and successful weaning from mechanical ventilation, with accompanying changes in immune cell markers suggesting reduced inflammation.

Summary

This case report describes an 85-year-old woman with a severe lung scarring disease (IgG4-related progressive fibrosing interstitial lung disease) who was on a breathing machine and also had a hospital-acquired infection. When treated with hydrogen gas therapy, her lung condition improved within four days and she was able to come off the breathing machine. Blood tests showed changes in immune cells after treatment: an increase in regulatory T cells (which calm down immune responses) and a decrease in activated T cells (which trigger immune responses).

Practical Takeaway

This is a single case report in one elderly patient, so it provides only preliminary evidence that hydrogen therapy may warrant further study in lung scarring diseases. Much larger and longer studies are needed before any conclusions can be drawn about whether hydrogen therapy could help patients with this condition. The case suggests a possible mechanism through immune system changes, but this requires confirmation in controlled research.

Abstract (excerpt)

Background/aim: Progressive fibrosing interstitial lung disease (PF-ILD) refers to a group of chronic lung conditions commonly associated with immunoglobulin G4-related disorders. It is characterized by progressive scarring (fibrosis) within the pulmonary interstitium, resulting in respiratory…

Read the full abstract via DOI